Pharmaceutical Company Rubicon Research's Shares List With Premium Of 28% Against ₹485 Issue Price
Published on: Oct. 16, 2025, 11:04 a.m. | Source: Free Press Journal
Proceeds from the fresh issue to the tune of Rs 310 crore would be used for debt repayment, and a portion would be allocated for inorganic growth through acquisitions, strategic initiatives, and general corporate purposes.
